Vanguard Group
COV

Vanguard Group’s COVIDIEN PLC COM SHS NEW (IRELAND) COV Stock Holding History

Vanguard Group’s Portfolio COV Stock Details COV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-22,912,022
Closed -$2.34B – 4224
2014
Q4 		$2.34B Buy
22,912,022
+764,340
+3% +$73.3M 0.17% 119
2014
Q3 		$1.92B Buy
22,147,682
+115,852
+0.5% +$10.3M 0.15% 132
2014
Q2 		$1.99B Buy
22,031,830
+428,996
+2% +$32.1M 0.16% 125
2014
Q1 		$1.59B Buy
21,602,834
+310,957
+1% +$21.7M 0.13% 147
2013
Q4 		$1.45B Buy
21,291,877
+138,739
+0.7% +$9.03M 0.13% 152
2013
Q3 		$1.29B Sell
21,153,138
-2,735,861
-11% -$167M 0.13% 149
2013
Q2 		$1.33B Buy
+23,888,999
New +$1.38B 0.14% 135

Vanguard Group's COV Position: Q1 2015 in Review

Vanguard Group sold out of COVIDIEN PLC COM SHS NEW (IRELAND) (COV) in Q1 2015, closing a stake of 22,912,022 shares — an estimated $2.34B sold.

Vanguard Group first reported a position in COV in Q2 2013 and held it in 7 quarters. The position peaked at $2.34B in Q4 2014. 1 fund tracked by Wall St. Rank holds COV as of Q1 2015.

  • Vanguard Group reported no remaining COVIDIEN PLC COM SHS NEW (IRELAND) position as of Q1 2015 after selling out during the quarter.
  • Vanguard Group sold 22,912,022 COVIDIEN PLC COM SHS NEW (IRELAND) shares in Q1 2015, an estimated $2.34B.
  • Vanguard Group first reported a position in COVIDIEN PLC COM SHS NEW (IRELAND) in Q2 2013 and held it in 7 quarters.
  • Vanguard Group's COVIDIEN PLC COM SHS NEW (IRELAND) position peaked at $2.34B in Q4 2014.
  • 1 fund tracked by Wall St. Rank held COVIDIEN PLC COM SHS NEW (IRELAND) as of Q1 2015.

Based on Vanguard Group's 13F filing for Q1 2015, filed 14 May 2015.